SANUWAVE Health Inc
OTC:SNWV

Watchlist Manager
SANUWAVE Health Inc Logo
SANUWAVE Health Inc
OTC:SNWV
Watchlist
Price: 32.695 USD -3.55% Market Closed
Market Cap: 280.5m USD

SANUWAVE Health Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

SANUWAVE Health Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
SANUWAVE Health Inc
OTC:SNWV
Revenue
$41.3m
CAGR 3-Years
39%
CAGR 5-Years
84%
CAGR 10-Years
48%
Boston Scientific Corp
NYSE:BSX
Revenue
$19.4B
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Revenue
$24.4B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$43.8B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
IDEXX Laboratories Inc
NASDAQ:IDXX
Revenue
$4.2B
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
10%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$9.6B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
15%
No Stocks Found

SANUWAVE Health Inc
Glance View

Market Cap
280.4m USD
Industry
Health Care

SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Suwanee, Georgia and currently employs 43 full-time employees. The company went IPO on 2008-11-07. The firm's is focused on regenerative medicine utilizing noninvasive, acoustic shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body’s normal healing processes and regeneration. The firm's lead regenerative product in the United States is the dermaPACE device, used for treating diabetic foot ulcers. The company intends to apply its Pulsed Acoustic Cellular Expression (PACE) technology in wound healing, orthopedic, plastic/cosmetic and cardiac conditions.

SNWV Intrinsic Value
33.26 USD
Undervaluation 2%
Intrinsic Value
Price

See Also

What is SANUWAVE Health Inc's Revenue?
Revenue
41.3m USD

Based on the financial report for Sep 30, 2025, SANUWAVE Health Inc's Revenue amounts to 41.3m USD.

What is SANUWAVE Health Inc's Revenue growth rate?
Revenue CAGR 10Y
48%

Over the last year, the Revenue growth was 41%. The average annual Revenue growth rates for SANUWAVE Health Inc have been 39% over the past three years , 84% over the past five years , and 48% over the past ten years .

Back to Top